Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital

Saudi Medical Journal

Volumn 27, Issue 1, 2006, Pages 37-40

  El Khizzi, Noura A ^a   Bakheshwain, Saadia M ^a  

^a Armed Foces Hospital ^*  (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ANALYTIC METHOD; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIFFUSION; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL LABORATORY; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; NONHUMAN; PREVALENCE; PUBLIC HOSPITAL; SAUDI ARABIA; STANDARDIZATION; TERTIARY HEALTH CARE; TEST STRIP; TREATMENT PLANNING;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, MILITARY; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SAUDI ARABIA;

EID: 32044432836     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wood AJ. Antimicrobial-drug resistance. N Eng J Med 1996; 335: 1445-1453.
2. D'Agata FEMC. Antibiotic resistance and exposure to different generation cephalosporins. N Eng J Med 2000; 28: 2678-2681.
3. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-252.
4. Pitout JD, Sanders CC, Sanders WE Jr. Antimicrobial resistance with focus on β-lactam resistance in gram-negative bacilli. Am J Med 1997; 103: 51-59.
5. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
6. Jacoby GA, Bush K. Amino acid sequence for TEM, SHV and Oxa extended spectrum and inhibitor resistance β-lactamases. (Cited March 2001). Available from http.//www.lahey.org/studies/wbt.htm.
7. Bush K. Is it important to identify extended spectrum β-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis 1996; 15: 361-364.
8. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF. Detection and reporting of organisms producing extended spectrum β-lactamases; Survey of Laboratories in Connecticut. J Clin Microbiol 1999; 37: 4065-4070.
9. Paterson DL, Yu VL. Extended-Spectrum β-lactamases: a call for improved detection and control (editorial). Clin Infect Dis 1999; 29: 1419-1422.
10. Andrews JM. BSAC Standardized disc susceptibility testing method. J Antimicrobial Chemother 2000; 46 (Suppl 1): 39-52.
11. Goossens H. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibility between countries and center types. J Antimicrob Chemother 2000; 46 (Suppl T2): 39-52.
12. Andrews JM, BSAC Working Party On Susceptibility Testing ft. BSAC standardized susceptibility testing method. J Antimicrob Chemother 2001; 48 (Suppl S1): 43-57.
13. Pagani L, Perilli M, Migliavacca R, Lazzaro F, Amicosante G. Extended-Spectrum TEM- and SHV-type b-lactamase-producing Klebsciella pneumoniae strains causing outbreaks in intensive care units in Italy. Eur J Clin Microbiol Infect Dis 2000; 19: 765-772.
14. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119: 353-358.
15. Karas JA, Pillay DG, Muckart D, Sturm AW. Treatment failure due to extended spectrum β-lactamase. J Antimicrob Chemother 1996; 37: 203-204.
16. Quinn JP. Clinical significance of extended spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl 1): S39-42.
17. Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996; 34: 908-911.
18. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
19. Stobberingh EE, Arends J, Hoogkamp-Korstanje JAA, Goessens WHF, Visser MR, Buiting AGM, et al. Occurrence of extended-spectrum β-lactamases (ESBL) in Dutch hospitals. Infection 1999; 27: 348-354.
20. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN; Sentry APAC Study Group. Prevalence of extended-spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002; 42: 193-198.
21. Babay HA. Detection of extended β-lactamases in members of the family Enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J 2002, 23: 186-190.
22. Bilal NE, Gedebou M. Clinical and community strains of Klebsiella pneumoniae: multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci 2000; 57: 185-191.
23. Kader AA, Kumar KA. Prevalence of ESBL among multidrug resistance gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 2004; 25: 570-574.
24. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta-lactamase producing Gram negative bacteria in tertiary care hospital. Indian J Med Res 2002; 115: 153-157.
25. Shah AA, Hasan F, Ahmed S, Hameed A. Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender. New Microbiol 2002; 25: 363-366.
26. Coudron PE, Moland ES, Sanders CC. Occurrence and detection of Extended-Spectrum β-Lactamase in members of Enterobacteriaceae of a veterans Medical Center: Seek and You May Find. J Clin Microbiol 1997; 35: 2593-2597.
27. Bantar C, Famiglietti A, Goldberg M. Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial committee; and National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000; 4: 85-90.
28. Albertini MT, Benoit C, Berardi L, Berrouane Y, Boisivon A, Cahen P, et al. Microbiology Surveillance Network of Northern France. Surveillance of methicillin-resistance Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) in Northern France: a five-year multicentre incidence study. J Hosp Infect 2002; 52: 107-113.
29. Ramadan MA, Tawfik AF, Shibl AM. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics. Chemotherapy 1995; 41:193-199.